Date:7/7/2009

re-IND Application of PLX-I II-41 Merck Pharmaceuticals Commences Phase I Study for R763 Kinase Inhibitor II-41 Swissmedic Approves Celgene's REVLIMID Oral Cancer Drug II-42 Celgene's REVLIMID Receives EU's Marketing Authorization II-42 FDA Approves Application of Piramal's IND-P276 Multiple Myeloma Drug II-42 Millennium Pharmaceuticals and Johnson & Johnson Initiate Velcade(R) Phase II Trial II-42 FDA to Consider the New Drug Application Filed for Use of Doxil(R) Combined with Velcade(R) in Patients with Multiple Myeloma II-42 Ortho Biotech Files Application with FDA for Approval of Combination Drug DOXIL(R) and VELCADE(R) II-43 Caraco's Allopurinol Receives FDA Approval II-43 FDA Approves Thalomid(R) as Combination Therapy for Multiple Myeloma II-43 Revlimid(R) Obtains Regulatory Approval for the Treatment of Multiple Myeloma II-43 LymphoSign Inc. Announces Successful Completion of LS104 Drug's Pre-Clinical Testing II-43 Seattle Genetics Commences SGN-40 Phase I Clinical Trial II-44 FDA Approves Use of Revlimid(R) for Multiple Myeloma II-44 US FDA Approves Use of Thalidomide for Multiple Myeloma II-44 Ziopharm Oncology Receives Approval to Commence ZIO-101 and ZIO-201 Trial II-44 FDA Grants Approval for Use of VELCADE(R) for Patients with Mantle Cell Lymphoma II-44 4. Recent Industry Activity II-45 CytRx to Acquire Innovive II-45 Launch of Epoetin alfa Hexal II-45 PDL and Bristol-Myers Signs Agreement II-45 MNKD and LLS Conclude Joint Research Agreement II-45 MorphoSys and DSM Enter into Agreement II-46 StemCyte Enters into Joint Venture with Cadila and Apollo Hospitals in India II-46 ImmunoCellular Acquires Molecular Antibody Technology II-46 US House of Representatives Sanction the Hematological Cancer Research Investment and Education Act II-46 Bayer and Cell Ther
'/>"/>

SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine news :

1. Virginia Tech Report Has National Importance
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
4. Haemacure Reports Third Quarter 2007 Results
5. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
6. Biotech Finishes on a High in August, Burrill Report Says
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. First New York/New Jersey Health Care Report Card Released
11. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007